CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
-13.82%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$6.51B
AUM Growth
+$6.51B
(-13%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
900
New
86
Increased
332
Reduced
273
Closed
84
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$52.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$29.4M |
| 3 |
Biogen
BIIB
|
$18.6M |
| 4 |
Mastercard
MA
|
$17.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
$17.5M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$50.7M |
| 2 |
Ecopetrol
EC
|
$21.5M |
| 3 |
AET
Aetna Inc
AET
|
$20.2M |
| 4 |
Amgen
AMGN
|
$19.2M |
| 5 |
Merck
MRK
|
$18.5M |
Sector Composition
| 1 | Healthcare | 35.32% |
| 2 | Technology | 15.37% |
| 3 | Financials | 11.61% |
| 4 | Consumer Discretionary | 8.19% |
| 5 | Communication Services | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amgen
AMGN
$155B
| $190M | 2.92% | 976,575 -98,475 | -9% | -$19.2M |
|
|
2
Biogen
BIIB
$19.4B
| $171M | 2.63% | 569,741 +61,805 | +12% | +$18.6M |
|
3
Microsoft
MSFT
$3.77T
| $160M | 2.46% | 1,575,263 +160,008 | +11% | +$16.3M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $135M | 2.08% | 2,111,324 +825,120 | +64% | +$52.9M |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $130M | 2.01% | 349,354 +2,971 | +0.9% | +$1.11M |
|
6
Amazon
AMZN
$2.44T
| $128M | 1.96% | 84,928 +8,605 | +11% | +$12.9M |
|
7
Apple
AAPL
$3.45T
| $113M | 1.74% | 718,656 +74,747 | +12% | +$11.8M |
|
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $105M | 1.62% | 635,385 +177,234 | +39% | +$29.4M |
|
9
Alphabet (Google) Class A
GOOGL
$2.57T
| $101M | 1.56% | 96,949 -6,464 | -6% | -$6.75M |
|
10
Gilead Sciences
GILD
$140B
| $98.4M | 1.51% | 1,573,913 +234,620 | +18% | +$14.7M |
|
11
Alibaba
BABA
$322B
| $78.7M | 1.21% | 574,395 +17,023 | +3% | +$2.33M |
|
|
12
Merck
MRK
$210B
| $76.4M | 1.17% | 1,000,057 -241,813 | -19% | -$18.5M |
|
13
Procter & Gamble
PG
$368B
| $71.6M | 1.1% | 778,671 -112,192 | -13% | -$10.3M |
|
|
14
Bristol-Myers Squibb
BMY
$96B
| $70.8M | 1.09% | 1,362,502 +335,865 | +33% | +$17.5M |
|
15
Illumina
ILMN
$15.8B
| $69.3M | 1.07% | 231,110 +46,155 | +25% | +$13.8M |
|
16
Visa
V
$683B
| $63.2M | 0.97% | 478,888 -7,853 | -2% | -$1.04M |
|
|
ALXN
17
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $60.9M | 0.94% | 625,897 +145,077 | +30% | +$14.1M |
|
18
Meta Platforms (Facebook)
META
$1.86T
| $60.6M | 0.93% | 462,324 -58,274 | -11% | -$7.64M |
|
19
Walt Disney
DIS
$213B
| $57.1M | 0.88% | 521,145 -35,504 | -6% | -$3.89M |
|
20
UnitedHealth
UNH
$281B
| $52.9M | 0.81% | 212,298 +66,712 | +46% | +$16.6M |
|
21
Home Depot
HD
$405B
| $51.9M | 0.8% | 301,897 +19,677 | +7% | +$3.38M |
|
22
AbbVie
ABBV
$372B
| $50.5M | 0.78% | 547,354 +26,953 | +5% | +$2.48M |
|
23
JPMorgan Chase
JPM
$829B
| $49.9M | 0.77% | 510,696 -29,237 | -5% | -$2.85M |
|
24
Johnson & Johnson
JNJ
$427B
| $48.7M | 0.75% | 377,524 -47,205 | -11% | -$6.09M |
|
25
Exxon Mobil
XOM
$487B
| $46.6M | 0.72% | 683,472 -250,004 | -27% | -$17M |
|